glp-1 management digital health startups

glp-1 management digital health startups How companies are capitalizing on the boom private digital health companies obesity

Name: glp-1 management digital health startups How companies are capitalizing on the boom private digital health companies obesity
Brand: gerloff.com
SKU: 19953348640
Price: 29.24 USD
Availability: InStock
Rating: 4.1071 (10 reviews)

SKU: 19953348640

4.1

EUR29.24 EUR65.24

Pay in 4 interest-free payments of $7.31 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Establish regular monitoring with your healthcare team

Studies have found GLP-1RA discontinuation rates of 36%81% in the first year of treatment

Phase III studies enrolled more than 1,400 patients and demonstrated that exenatide effectively lowered blood glucose while producing an unexpected but welcome side effect: weight loss

Slowing Gastric Emptying : By delaying the emptying of the stomach, it helps control appetite and reduces food intake

This weight regain is not due to medication "dependence" in the traditional sense, but rather reflects the underlying biology of obesity as a chronic condition